The city of Atlanta, Georgia, currently has 28 active clinical trials seeking participants for Diabetes research studies.
Closed Loop Glucose Control in Patients With Type 1 and Type 2 Diabetes
Recruiting
This is a proof of concept safety study of an artificial intelligence based closed loop glucose control system designed for use in the intensive care unit setting. The type 1 and type 2 diabetic subjects in this study will have their glucose controlled to a range of 100-140 mg/dL by a novel artificial intelligence based closed loop glucose control system for a period of 24 hours. The subjects will consume three standardized meals during the 24 hour study period.
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
12/31/2022
Locations: Emory University, Atlanta, Georgia
Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Dietary Oxysterols and β-Cell Function Among African Americans
Recruiting
African Americans (AAs) have a higher risk of developing type 2 diabetes than the general population. AAs are also more likely to eat foods that contain cholesterol oxides/oxysterols. Dietary oxysterols can harm the cells that produce insulin and decrease insulin production. This pilot study seeks to determine if removing dietary oxysterols with a plant-based diet will improve insulin production and decrease the risk of type 2 diabetes among AAs.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/08/2021
Locations: Morehouse School of Medicine, Atlanta, Georgia
Conditions: Type 2 Diabetes
Continuous Monitoring and Control of Hypoglycemia
Recruiting
Evaluate safety of non-adjunctive CGM use in CGM naive participants.
Gender:
All
Ages:
2 years and above
Trial Updated:
09/17/2021
Locations: Atlanta Diabetes, Atlanta, Georgia
Conditions: Diabetes
Evaluation of Medtronic DUO Extended Set
Recruiting
This study is a single-center, non-randomized, prospective single arm study of adult subjects with type 1 diabetes utilizing 670G insulin pump therapy with Continuous Glucose Monitoring (CGM). These subjects will be using 4 DUO Extended sets that will serve as an exploratory pilot study to assess the 7-day survival of the Duo Extended set.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
03/29/2021
Locations: Atlanta Diabetes Associates, Atlanta, Georgia
Conditions: Diabetes Mellitus, Type 1